R&D Tax Incentive for Manufacturers
Manufacturing R&D is one of the most underclaimed categories in Australia, not because manufacturers don't qualify, but because most don't realise their process, product, and materials work meets the criteria. We help manufacturers identify what qualifies, document it correctly, and build claims that hold up at review.
Does Manufacturing Work Qualify for the RDTI?
Yes, and it qualifies more often than most manufacturers expect.
The most common reason manufacturers miss out is a mistaken belief that the RDTI is for biotech companies and research laboratories. It is not. The legislation applies equally to any industry where companies attempt to resolve technical problems through systematic experimentation, and manufacturing is full of exactly that kind of work.
The three RDTI tests apply to manufacturing just as they do in software or medtech:
- Technical uncertainty - would a competent manufacturing engineer or materials scientist know the answer before running the trials? If not, uncertainty may exist
- Systematic experimentation - are you forming a hypothesis, running controlled tests, and drawing conclusions from the results? Not just running batches
- New knowledge - are you generating insights into material behaviour, process parameters, or product performance that aren't publicly available?
The challenge in manufacturing is not usually whether R&D occurred, it's drawing the correct boundary between the R&D phase and normal production, and framing the work in technical rather than commercial terms.
For the full legislative framework, see our RDTI eligibility guide.
Manufacturing R&D: What Qualifies and What Doesn't
The line between qualifying and non-qualifying activity is about technical uncertainty and experimental method, not effort, cost, or whether the work was labelled as R&D internally.
✅ LIKELY QUALIFIES:
- Developing a new product formulation requiring iterative material testing with uncertain performance outcomes, for example, reformulating a food product to remove preservatives while maintaining shelf life and structural integrity
- Designing a new manufacturing process where optimal equipment settings, temperatures, pressures, or sequencing are unknown and must be determined through controlled production trials
- Experimenting with new alloys, composites, or material combinations to achieve structural, thermal, or chemical properties not achievable with existing materials
- Pilot plant trials to validate a new process before full scale-up, where yields and quality parameters are genuinely uncertain at pilot scale
- Developing custom production control systems or automation where the technical architecture and integration approach involve unresolved engineering challenges
- Integrating new manufacturing technologies, such as robotics, advanced sensors, or closed-loop control, into existing production lines with uncertain compatibility outcomes
❌ DOES NOT QUALIFY:
- Routine production runs following established specifications, even if the product or process is new to your facility
- Compliance with GMP, ISO standards, TGA registration, or other regulatory requirements - this is explicitly excluded by the legislation
- Market testing, consumer trials, or commercial validation of a finished product
- Production that continues after R&D specifications have been confirmed and technical targets met, even on the same product line
For expenditure rules, including how to treat plant, equipment, and contractor costs, see the R&D Tax Incentive overview.
What's Different About Manufacturing RDTI Claims
Manufacturing claims have specific risks and structural features that don't arise in other sectors. These are the areas we focus on most closely.
The R&D-to-production boundary
This is the most common ATO challenge point for manufacturing claims. Once a core R&D activity's technical specifications are confirmed and the target knowledge is generated, further production activity loses its eligibility, even if it involves the same product, process, or equipment. Manufacturers must document exactly when R&D ends: batch records, project milestones, and signed-off technical specifications establish this boundary. Claims that blur this line by including production costs in the R&D claim are the most frequent cause of adjustments after review.
Grant funding and RDTI - the clawback risk
Many manufacturers receive government grants alongside undertaking RDTI-eligible work, including federal programs like the Modern Manufacturing Initiative, state-based industry grants, and export market development grants. Expenditure already funded by a grant cannot be double-counted in an RDTI claim. The clawback provisions apply and can significantly reduce a claim if not managed upfront. The solution is planning the grant/RDTI expenditure split before costs are incurred, retroactive coordination is messy and often leaves money on the table. We build this split into your project accounting from the start.
Plant and equipment - a significant but often missed cost
Depreciation of equipment used during R&D trials is an eligible expenditure category, and for manufacturers, this can represent a substantial portion of the total claim. The equipment must be demonstrably used for R&D rather than production, and the R&D period must be documented through trial logs, equipment booking records, and batch documentation. Vague claims that "the machine was used for R&D testing" without supporting records do not survive scrutiny.
Pilot scale and scale-up uncertainty
Pilot plant work often qualifies, but only if genuine technical uncertainty persists at the pilot scale. If a process is already confirmed at laboratory scale and the pilot is simply confirming commercial viability, the technical uncertainty may already be resolved. Conversely, if scaling from lab to pilot introduces new unknowns, such as flow dynamics, heat transfer, or yield variation, those unknowns can independently qualify. The distinction requires careful analysis of what was known at each stage.
The regulatory compliance exclusion
Testing and validation work conducted for the purpose of meeting GMP requirements, TGA registration, food safety standards, or ISO certification is explicitly excluded from RDTI, regardless of how technical or expensive it is. This exclusion catches food and medical device manufacturers, and especially pharmaceutical and biotech companies, who confuse regulatory compliance with R&D. Activities performed to generate new knowledge qualify; activities performed to demonstrate compliance with a known standard do not.
How We Help Manufacturers
R&D Boundary Mapping
We identify exactly where your R&D activities end and normal production begins, the most common challenge point in manufacturing claims. This involves reviewing batch records, project milestones, and trial documentation to establish a defensible production boundary before lodgement.
Grant and RDTI Coordination
We map your grant funding against eligible RDTI expenditure to maximise your combined government support without triggering clawback. The optimal approach directs grant funds toward ineligible costs, but this requires planning before costs are incurred, not after.
Plant and Equipment Costs
We identify eligible depreciation and operating costs for equipment used during R&D trials, supported by equipment usage logs and batch documentation. For capital-intensive manufacturers, this category can significantly increase the total claim value.
Audit-Ready Documentation
Manufacturing claims require batch records, trial logs, technical specifications, and equipment timesheets. We review your existing operational records and identify gaps early, so your evidence package is assembled before lodgement, not assembled under pressure during a review.
Manufacturing RDTI: Frequently Asked Questions
Can manufacturers claim for process improvement work?
Yes, process improvement qualifies when the optimal parameters, materials, or methods are genuinely uncertain and resolved through systematic experimentation. Iterative production trials to determine equipment settings, yield, and quality outcomes are a common qualifying example. Routine optimisation of a known process using established methods does not qualify. See our eligibility guide for the core activity criteria in full.
We receive government grants - can we still claim RDTI for the same project?
Yes, but not for the same expenditure. Costs funded by a grant cannot be included in your RDTI claim, doing so triggers clawback provisions that reduce your offset dollar-for-dollar. The practical solution is to plan the split upfront: direct grant funds toward ineligible costs so your RDTI claim captures eligible expenditure that grants don't cover. We help structure this before costs are incurred to maximise your total government support.
At what point does pilot plant or scale-up work stop qualifying?
Pilot and scale-up work qualifies as long as genuine technical uncertainty remains, that is, the process specifications, yield, or quality outcomes are not yet confirmed. Once R&D targets are met and the process is established, further production runs are ineligible even if they are the first at commercial scale. This boundary must be documented with batch records and signed-off project milestones. See our claim process guide for how we structure the documentation.
What records do we need to support a manufacturing RDTI claim?
The ATO requires contemporaneous records showing technical uncertainty at the start of each activity and systematic experimentation throughout. For manufacturers this typically means: project plans and technical specifications, dated batch records and trial logs, equipment usage records linked to R&D phases, timesheets for staff involved in R&D activities, and test results with analysis. The key is that records must distinguish R&D phases from normal production, and exist at the time of the work, not be reconstructed afterwards.
Manufacturing R&D Assessment
If your business is developing new products, trialling new processes, or experimenting with new materials, and you haven't claimed the RDTI, it's worth finding out what you've been missing.